
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases
Han‐Na Kim, Eun‐Jeong Joo, Hae Suk Cheong, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 8, pp. 1089-1089
Open Access | Times Cited: 53
Han‐Na Kim, Eun‐Jeong Joo, Hae Suk Cheong, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 8, pp. 1089-1089
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 348
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 348
Correlation and association analyses in microbiome study integrating multiomics in health and disease
Yinglin Xia
Progress in molecular biology and translational science (2020), pp. 309-491
Closed Access | Times Cited: 165
Yinglin Xia
Progress in molecular biology and translational science (2020), pp. 309-491
Closed Access | Times Cited: 165
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Silvia Sookoian, Adrián Salatino, Gustavo Castaño, et al.
Gut (2020) Vol. 69, Iss. 8, pp. 1483-1491
Open Access | Times Cited: 157
Silvia Sookoian, Adrián Salatino, Gustavo Castaño, et al.
Gut (2020) Vol. 69, Iss. 8, pp. 1483-1491
Open Access | Times Cited: 157
Gut microbiota and metabolic health among overweight and obese individuals
Mi-Hyun Kim, Kyung Eun Yun, Jimin Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 116
Mi-Hyun Kim, Kyung Eun Yun, Jimin Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 116
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
Ashiq Khan, Zitong Ding, Muhammad Ishaq, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 818-833
Open Access | Times Cited: 85
Ashiq Khan, Zitong Ding, Muhammad Ishaq, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 818-833
Open Access | Times Cited: 85
Links between gut microbiome composition and fatty liver disease in a large population sample
Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 62
Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 62
Lentinan Supplementation Protects the Gut–Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved
Xiaoying Yang, Mingxuan Zheng, Menglu Zhou, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 50
Xiaoying Yang, Mingxuan Zheng, Menglu Zhou, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 50
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 29
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 29
The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
Huanzhuo Mai, Xing Yang, Yulan Xie, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Huanzhuo Mai, Xing Yang, Yulan Xie, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Apple Polyphenol Extract Improves High-Fat Diet-Induced Hepatic Steatosis by Regulating Bile Acid Synthesis and Gut Microbiota in C57BL/6 Male Mice
Deming Li, Yuan‐Lu Cui, Xinjing Wang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 24, pp. 6829-6841
Closed Access | Times Cited: 48
Deming Li, Yuan‐Lu Cui, Xinjing Wang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 24, pp. 6829-6841
Closed Access | Times Cited: 48
The Effect of Lithocholic Acid on the Gut-Liver Axis
Wei Sheng, Guang Ji, Li Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Wei Sheng, Guang Ji, Li Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
The role of microbiota in nonalcoholic fatty liver disease
Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 7
Closed Access | Times Cited: 29
Agostino Di Ciaula, Leonilde Bonfrate, Piero Portincasa
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 7
Closed Access | Times Cited: 29
Chicory: Understanding the Effects and Effectors of This Functional Food
Céline L. Pouille, Souad Ouaza, Elise Roels, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 957-957
Open Access | Times Cited: 28
Céline L. Pouille, Souad Ouaza, Elise Roels, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 957-957
Open Access | Times Cited: 28
Composition of gut microbiota and non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Xin Su, Shiyun Chen, Jiazi Liu, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Closed Access | Times Cited: 22
Xin Su, Shiyun Chen, Jiazi Liu, et al.
Obesity Reviews (2023) Vol. 25, Iss. 1
Closed Access | Times Cited: 22
Probiotic supplementation for 24 weeks in patients with non-alcoholic steatohepatitis: the PROBILIVER randomized clinical trial
Amanda Souza Silva-Sperb, Helena Abadie Moraes, Samantha Thifani Alrutz Barcelos, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 6
Amanda Souza Silva-Sperb, Helena Abadie Moraes, Samantha Thifani Alrutz Barcelos, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 6
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Sana Raza, Sangam Rajak, Baby Anjum, et al.
Hepatoma Research (2019) Vol. 2019
Open Access | Times Cited: 44
Sana Raza, Sangam Rajak, Baby Anjum, et al.
Hepatoma Research (2019) Vol. 2019
Open Access | Times Cited: 44
Lactobacillus acidophilus LA14 Alleviates Liver Injury
Longxian Lv, Chunyan Yao, Yan Ren, et al.
mSystems (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 36
Longxian Lv, Chunyan Yao, Yan Ren, et al.
mSystems (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 36
Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
Joo Hyun Oh, Jehee Lee, Min Seok Cho, et al.
Nutrients (2021) Vol. 13, Iss. 3, pp. 1013-1013
Open Access | Times Cited: 33
Joo Hyun Oh, Jehee Lee, Min Seok Cho, et al.
Nutrients (2021) Vol. 13, Iss. 3, pp. 1013-1013
Open Access | Times Cited: 33
Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
Lihong He, Dun-Han Yao, Lingyun Wang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 33
Lihong He, Dun-Han Yao, Lingyun Wang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 33
Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
Xia Yi, Mengting Ren, Jinpu Yang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 24
Xia Yi, Mengting Ren, Jinpu Yang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 24
Reversion of Gut Microbiota during the Recovery Phase in Patients with Asymptomatic or Mild COVID-19: Longitudinal Study
Han‐Na Kim, Eun‐Jeong Joo, Chil-Woo Lee, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1237-1237
Open Access | Times Cited: 30
Han‐Na Kim, Eun‐Jeong Joo, Chil-Woo Lee, et al.
Microorganisms (2021) Vol. 9, Iss. 6, pp. 1237-1237
Open Access | Times Cited: 30
Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae
Iñaki Milton‐Laskibar, Amanda Cuevas‐Sierra, María P. Portillo, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1797-1797
Open Access | Times Cited: 21
Iñaki Milton‐Laskibar, Amanda Cuevas‐Sierra, María P. Portillo, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1797-1797
Open Access | Times Cited: 21
Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
Haiying Wang, Qiang Wang, Cui-Mei Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Haiying Wang, Qiang Wang, Cui-Mei Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Mitigation of high-fat diet-induced hepatic steatosis by thyme (Thymus quinquecostatus Celak) polyphenol-rich extract (TPE): insights into gut microbiota modulation and bile acid metabolism
Xialu Sheng, Ping Zhan, Peng Wang, et al.
Food & Function (2024) Vol. 15, Iss. 14, pp. 7333-7347
Closed Access | Times Cited: 4
Xialu Sheng, Ping Zhan, Peng Wang, et al.
Food & Function (2024) Vol. 15, Iss. 14, pp. 7333-7347
Closed Access | Times Cited: 4
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease
Emidio Scarpellini, Marialaura Scarcella, Jan Tack, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1386-1386
Open Access | Times Cited: 4
Emidio Scarpellini, Marialaura Scarcella, Jan Tack, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1386-1386
Open Access | Times Cited: 4